Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives

29 Aug 2022 · Paul Langley
Podcast - IR Department talks to Race Oncology's CSO Dr Daniel Tillett
Interview with Race Oncology’s CSO Dr Daniel Tillett
Read article
29 Aug 2022 · Paul Langley
Mosquito-borne diseases in Australia - an interview with Dr David Foster, CEO of Island Pharmaceuticals
We speak with Dr David Foster, CEO & Managing Director of Island Pharmaceuticals, about the current mosquito-borne diseases landscape in Australia. With recent outbreaks of dengue fever and Japane...
Read article
29 Aug 2022 · Paul Langley
Kazia Therapeutics CEO Dr James Garner talks with SmallCaps about what's on the horizon
Kazia Therapeutics (ASX: KZA) CEO James Garner joins Small Caps to discuss the company’s ongoing development of its lead drug paxalisib, which recently generated positive interim data in a phase one…
Read article
29 Aug 2022 · Paul Langley
Interview with Assoc.Prof. Mathias Francois of Gertrude Biomedical
We talk to Associate Professor Mathias Francois of Gertrude Biomedical, world-leaders in small molecular inhibitors to SOX18, a unique drug target with significant commercial and clinical potential
Read article
29 Aug 2022 · Paul Langley
HaemaLogiX's Tertia Dex explains the KappaMab antibody
HaemaLogix's Chief Manufacturing and Development Officer, Tertia Dex, explains the fascinating process to manufacture KappaMab, a highly-targeted antibody designed to treat mutliple myeloma.
Read article
04 Jul 2022 · Cherie Hartley
Podcast - IR Department talks with AdAlta CEO & MD, Dr Tim Oldham
Interview with AdAlta’s CEO & Managing Director Dr Tim Oldham
Read article
31 Mar 2022 · Paul Langley
IRD Invest March 2022 - Pureprofile
IRD Invest 31st March 2022 - "Project: 2025"
Read article
31 Mar 2022 · Paul Langley
IRD Invest March 2022 - Oventus
IRD Invest 31st March 2022 - "Project: 2025"
Read article
31 Mar 2022 · Paul Langley
IRD Invest March 2022 - Openpay
IRD Invest March 2022 - "Project: 2025"
Read article
25 Mar 2022 · Michael Lovesey
Register now for our next IRD Invest virtual investor conference, where emerging tech companies will talk about the tailwinds driving their businesses
Join our investor conference on 31 March – Technology focused virtual event!
Read article